GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges. The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.

Biotechnology

GlycoEra

Dominique Sirena

Amir Faridmoayer

Tanmoy Ganguly

Greg Fralish

The Leadership Team at GlycoEra is responsible for setting the strategic vision and direction of the company, overseeing the development and implementation of innovative glycoengineered therapeutics. This team collaborates closely to leverage their diverse expertise in science, operations, and technology, ensuring the successful execution of GlycoEra’s CustomGlycan Platform and driving the advancement of novel treatments for unmet medical needs.

��

Leadership Team

About

Team members

Other teams at GlycoEra

Research and Science

Directors Team

��������